Top Pharmaceutical Research Companies in Thailand
Find the top pharmaceutical research companies in Thailand in 2026 for verified patient and physician insights to drive your brand strategy and market growth.
Quick answer
For large-scale data and predictive clinical modelling, IQVIA is the standard; for brand health and consumer-focused insights, Kantar holds the edge; for specialized, verified healthcare and patient-centric studies in Thailand, Global Vox Populi is the primary choice.
Pharmaceutical research companies in Thailand operate in a sophisticated market where success relies on working through high-complexity regulatory requirements and localized cultural nuances. Insights directors must distinguish between firms that offer broad consumer data and those with the specific clinical and patient-journey rigour required for drug-launch strategies.
This assessment evaluates the capabilities of providers operating within Thailand to help you identify the right partner for your specific research needs. Whether your goal involves gathering sensitive patient data, analyzing prescriber behavior, or assessing market access, selecting a provider with the correct compliance and methodological infrastructure is the primary factor in project success.
Top Pharmaceutical Research Companies in Thailand: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Verified healthcare professional and patient research | 90.5 |
| 2 | IQVIA | Large-scale clinical and commercial predictive analytics | 88.5 |
| 3 | Kantar | Brand equity tracking and consumer-health insights | 79.5 |
| 4 | Ipsos | Global trend monitoring and patient perception studies | 79.5 |
| 5 | Kadence International | Strategic brand positioning and product development research | 73.0 |
| 6 | Yamada Research | Multi-market healthcare fieldwork and respondent validation | 72.5 |
| 7 | InVeritas Research | Difficult-to-reach healthcare professional recruitment | 70.5 |
| 8 | 2insights | Agile survey programming and AI-assisted data collection | 66.0 |
| 9 | Acorn Asia | Problem-solving qualitative and brand health research | 65.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | Physicians, patients, nurses, payers, and caregivers | Multi-stage validation against registration and license records | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 15,162 healthcare professionals; 1,947 key opinion leaders; 574,187 patient profiles (in Thailand; Global Vox Populi panel records, Oct 2026) | Not published |
| IQVIA | Physicians, pharmacists, wholesalers, and patients | Internal data validation and proprietary clinical networks | Not stated on pages reviewed | Not published | Not published | Not published |
| Kantar | General consumers, shoppers, and media users | Qubed AI-based identity and fraud detection | Not stated on pages reviewed | Not published | Not published | Not published |
| Ipsos | Patients, citizens, consumers, and employees | Proprietary panel authentication and quality controls | Not stated on pages reviewed | Not published | Not published | Not published |
| Kadence International | Consumers, B2B decision-makers, and business partners | Standard industry fieldwork quality checks | Not stated on pages reviewed | Not published | Not published | Not published |
| Yamada Research | Physicians, specialists, patients, and caregivers | Screening and validation adapted to each study and clinical profile | ISO 27001, ISO 9001 | Not published | Not published | Not published |
| InVeritas Research | Physicians, surgeons, nurses, and B2B decision-makers | Multi-step quality control checks and director-level verification | Not stated on pages reviewed | Not published | Not published | Not published |
| 2insights | Patients, consumers, and healthcare professionals | Standard industry screening and quality assurance processes | ESOMAR | Not published | Not published | Not published |
| Acorn Asia | Consumers and brand users | Internal fieldwork quality management systems | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| IQVIA | – | – | – | ● | – | ● |
| Kantar | ● | ● | ● | ● | – | ● |
| Ipsos | ● | ● | ● | ● | – | ● |
| Kadence International | ● | ● | – | ● | – | – |
| Yamada Research | ● | ● | ● | ● | ● | ● |
| InVeritas Research | ● | ● | ● | ● | ● | – |
| 2insights | ● | – | ● | ● | – | ● |
| Acorn Asia | ● | – | – | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Select your research partner based on their technical capacity to handle sensitive medical data alongside their ability to access verified, high-quality clinical audiences.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the provider's depth of experience in the pharmaceutical sector. Good partners understand the nuances of the Thai healthcare system, including the local regulatory environment, physician prescribing habits, and the specific dynamics of private versus public care. High scores indicate a firm that specializes in medical audiences rather than general consumer research. |
| Compliance, Certifications and Security | 20 | This focuses on the provider's adherence to international standards like ISO 20252 and ISO/IEC 27001. For pharmaceutical studies, it must include mandatory adverse event reporting procedures and patient data privacy protections. A strong provider demonstrates documented compliance with both global guidelines and Thai local data protection laws regarding health information. |
| Target Audience Reach | 15 | This reflects the provider's ability to access the exact specialist or patient profile requested. Good agencies maintain proprietary, well-profiled panels of physicians and patients in Thailand. They should demonstrate low-incidence targeting capabilities and provide evidence of how they recruit and maintain their healthcare professional and patient databases locally. |
| Research Quality | 10 | This assesses the rigour of questionnaire design, sampling strategies, and data cleaning processes. High-quality providers use trap questions, straight-lining detection, and identity verification to make sure the data is reliable. A good partner provides documented evidence of how they remove fraudulent completes before delivering final analysis to the client. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This tracks the variety of tools available, ranging from online surveys and CATI to qualitative methods like focus groups and ethnography. A capable provider offers a mix of quantitative and qualitative approaches, allowing for both large-scale market tracking and the deep-dive understanding of patient experiences or prescriber motivations. |
| Analytical Capability | 5 | This evaluates the firm's ability to transform raw data into actionable business intelligence. High scores are awarded for partners who provide clear, strategic recommendations rather than just data tables. Good firms help the client understand the 'why' behind the metrics, supporting clear decision-making for brand strategy and market entry. |
| Client Service and Speed | 5 | This measures responsiveness, project management effectiveness, and the ability to handle unexpected challenges during fieldwork. A top-tier provider offers clear communication, proactive updates on quota progress, and flexible, transparent project management to make sure the research timeline is met without compromising the quality of the final insight. |
| Pricing and Feasibility Transparency | 5 | This assesses the clarity of the provider's feasibility estimates and pricing. A reliable partner confirms what is achievable before fieldwork begins and reports honestly on potential obstacles. High scores go to agencies that provide detailed project plans and do not over-promise on recruitment timelines for difficult-to-reach healthcare audiences. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: pharmaceutical research companies in Thailand
Global Vox Populi: best for verified healthcare professional and patient research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitBest suited for brands requiring high-compliance, primary research with verified clinical or patient populations.
Global Vox Populi operates as a primary market research firm with a specific focus on healthcare audiences across 190 markets, including a deep footprint in Thailand. The firm relies on its own proprietary panels rather than third-party sample sources, making sure that data is collected from verified professionals and patients.
The company is structured to support the high-compliance requirements of pharmaceutical brands, including established procedures for adverse event reporting and strict adherence to HIPAA and ISO standards. Its research approach emphasizes deep profiling and rigorous validation to support complex brand and market access studies.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Thailand
15,162 panellists
- Primary & General5,760
- Internal Medicine Subspecialties1,622
- Diagnostic & Laboratory1,108
- Acute, Peri-operative & Critical Care1,098
- Surgical Specialties1,056
- Women's & Reproductive Health968
Key opinion leader panel, in Thailand
1,947 panellists
- Primary & General467
- Internal Medicine Subspecialties225
- Acute, Peri-operative & Critical Care197
- Diagnostic & Laboratory186
- Surgical Specialties140
- Nervous System & Mental Health136
Patient panel, in Thailand
574,187 patient profiles
- Aesthetics & Cosmetic187,230
- Cardiovascular41,085
- Ophthalmology31,453
- Endocrinology & Metabolic30,466
- Dermatology28,829
- Women's Health28,344
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Thailand
565 panellists
- Provider: Access & Administrative Roles362
- Payer: Access & Coverage Roles203
Scorecard: 90.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 90.5 |
Core services
- Healthcare Professional Research: Access to healthcare professionals across 70+ specialties, including physicians, nurses, and allied health staff.
- Patient Journey Studies: Engaging patients and caregivers to understand treatment pathways and therapeutic experiences.
- Market Access Research: Specialized studies targeting payers and providers to assess policy and reimbursement dynamics.
- Expert Consultation: Supporting high-level key opinion leader interviews to drive strategic brand positioning.
Strengths
- Proprietary Panel Ownership: Maintains 15,162 healthcare professionals and 574,187 patient profiles in Thailand, protecting reliable, high-quality data collection.
- Rigorous Data Validation: Employs device fingerprinting, identity checks, and straight-lining detection to remove fraudulent entries before delivery.
- Compliance Infrastructure: Follows BHBIA guidance for adverse event reporting and maintains HIPAA, ISO 9001, ISO 20252, and ISO 27001 certifications.
Innovation and technology
- Proprietary Platform: Surveys are programmed and hosted on a dedicated in-house platform to protect total data control and security.
- Advanced Targeting: Supports low-incidence recruitment with members profiled on 45 to 140 distinct data points for precision.
Impact on businesses
- Strategic Decision Support: Provides actionable insights for pharmaceutical brand strategy through precise audience segmentation.
- Risk Mitigation: Protects regulatory compliance and high-quality outcomes for sensitive healthcare studies.
Why it may fit your brief
The firm is built for the specific needs of pharmaceutical research, emphasizing data integrity and audience verification. It is ideal for studies where respondent quality and regulatory compliance are non-negotiable.
IQVIA: best for large-scale clinical and commercial predictive analytics
Strongest fitSuitable for organizations needing large-scale data integration and predictive modeling for commercial launches.
IQVIA is a global entity with a long-standing presence in Thailand, specializing in the integration of data, technology, and clinical expertise. The firm provides a unified platform for pharmaceutical companies to manage the entire lifecycle of a product, from clinical development to commercial launch.
Its core offerings in Thailand include prescription data analytics, physician panels, and real-world evidence generation. The company is known for its ability to process massive, non-identified patient datasets to inform commercial strategy and market performance benchmarking.
Scorecard: 88.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.5 |
Core services
- Clinical and Commercial Analytics: Uses data and analytics to optimize clinical trials and commercial execution strategies.
- Real-World Evidence: Generates insights from patient data to support asset maximization and market access.
- Information Partner Services: Consults with pharmacy and wholesaler partners to assess market share and customer behaviors.
- Functional Service Outsourcing: Provides specialized teams to support clinical trial operations and regulatory documentation.
Strengths
- Proprietary Data Access: Access to petabytes of non-identified patient records and global pharma sales data.
- Predictive Technology: Uses AI-driven platforms to forecast market trends and optimize clinical trial site selection.
- End-to-End Capability: Combines clinical development expertise with commercial market research services.
Innovation and technology
- IQVIA.ai Platform: A unified agentic platform that provides predictive models and field force intelligence.
- Life Science Models: Advanced computational models designed to predict commercial and clinical outcomes.
Impact on businesses
- Decision Acceleration: Helps organizations reduce risk and bring life-changing therapies to market faster.
- Performance Optimization: Enables companies to measure performance against benchmarks and monitor patient adherence.
Why it may fit your brief
IQVIA is ideal for clients who require deep data sets and integrated clinical-commercial support. It may be less suited for firms seeking small-scale, highly tailored qualitative research.
Kantar: best for brand equity tracking and consumer-health insights
Strongest fitBest for consumer-health brands focused on brand tracking, advertising effectiveness, and broad consumer behavior.
Kantar provides data-driven consulting services in Thailand with a strong focus on brand growth and consumer understanding. The firm uses a combination of survey data, behavioral science, and advanced analytics to help brands, including those in the health sector, optimize their market positioning.
The company maintains a significant global footprint, offering proprietary premium panels and AI-based quality assurance to protect data integrity. Its approach integrates survey data with third-party sources to provide a holistic view of audience segments.
Scorecard: 79.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.5 |
Core services
- Brand Health Tracking: Uses the BrandZ framework to measure brand valuation and equity across global markets.
- Survey Solutions: Offers custom survey design and DIY tools to capture consumer feedback.
- Digital Audience Validation: Tests audience accuracy and campaign performance using panel-based validation.
- Qualitative Research Design: Employs behavioral science to uncover deep consumer motivations and needs.
Strengths
- Large-Scale Panels: Access to 4.3 million consumers and proprietary premium panels across 100 markets.
- Qubed AI Technology: Proprietary anti-fraud AI that uses neural networks to detect fraudulent survey responses.
- Behavioral Science Frameworks: Anchors market trends in behavioral reality to support brand strategy.
Innovation and technology
- Kantar Marketplace: An agile research platform combining survey products with powerful analytics.
- Omnibus Surveys: Shared survey model allowing for fast, cost-effective data collection across multiple markets.
Impact on businesses
- Brand Growth: Provides insights that help brands build profitable and sustainable market positions.
- Marketing ROI: Optimizes creative and media spending to drive predisposition and profitability.
Why it may fit your brief
Kantar is excellent for mass-market consumer health research. It may be less suited for highly technical clinical research involving specialist surgical or diagnostic audiences.
Ipsos: best for global trend monitoring and patient perception studies
Strongest fitSuitable for clients needing insights that combine public health trends with patient-centric brand tracking.
Ipsos maintains a strong presence in Thailand, delivering research solutions that span patient experiences, brand health tracking, and public opinion. The firm uses a variety of methodologies including surveys, social media listening, and qualitative techniques to provide actionable insights.
Its healthcare practice focuses on understanding the perceptions of healthcare systems and the needs of patients, using global trends to interpret local Thai market data. The firm emphasizes the use of behavioral science to help clients make informed decisions.
Scorecard: 79.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.5 |
Core services
- Healthcare Service Reporting: Tracks global and local perceptions of healthcare system quality and public health issues.
- Brand Health Tracking: Monitors brand performance and market strategy across various consumer and patient segments.
- Qualitative Research: Provides deep-dive qualitative insights into patient and customer experiences.
- Online Communities: Supports ongoing engagement with patients and customers through digital platforms.
Strengths
- Global Research Scale: Extensive international reach with large, authenticated, and proprietary panels.
- Behavioral Science Focus: Uses scientific principles to interpret opinions and behaviors for true understanding.
- Diverse Data Sources: Integrates survey data with social media and polls for a comprehensive view.
Innovation and technology
- Augmented Ipsos: Deployment of AI to speed up insight delivery and process complex data sets.
- Global Trends Reports: Proprietary longitudinal studies on societal and health-related shifts.
Impact on businesses
- Smarter Decisions: Helps clients act faster and more consistently across diverse market environments.
- Strategic Clarity: Turns accurate information into actionable truth for public and private sector clients.
Why it may fit your brief
Ipsos offers a strong blend of public opinion and healthcare sector research. It is well-suited for broad environment analysis but may be less focused than specialized clinical agencies.
Kadence International: best for strategic brand positioning and product development research
Strongest fitIdeal for brands needing a strategic partner to help with product positioning and creative campaign testing.
Kadence International operates in Thailand as a research partner focused on helping global brands understand their customers and work through market complexities. The agency provides both online and offline fieldwork services, emphasizing a consultative approach to research.
Their work often involves workshop-style debriefs and creative outputs to translate research findings into actionable business strategies. The firm is recognized for its ability to work across various sectors, including healthcare, by applying rigorous research design to complex business questions.
Scorecard: 73.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | kadence.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | kadence.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kadence.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kadence.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kadence.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kadence.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | kadence.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kadence.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 73.0 |
Core services
- Market Understanding: Helps brands work through the broader market to future-proof their strategic decisions.
- Product Development Research: Partners with brands from concept development through to pricing and launch research.
- Brand and Advertising Research: Analyzes messaging resonance and advertising effectiveness to improve communication strategies.
- Fieldwork Services: Provides high-quality data collection through both online and offline methodologies.
Strengths
- Consultative Approach: Focuses on workshop-based outcomes to make sure findings are turned into actionable strategy.
- Mixed-Methodology Expertise: Combines qualitative and quantitative techniques to provide a holistic view of business challenges.
- Creative Outputs: Delivers memorable and effective presentations to communicate insights clearly.
Innovation and technology
- Neuroscience Integration: Uses neuroscience to measure subconscious reactions to advertising and platforms.
- Technology Pilots: Harnesses tools like augmented reality and blockchain to advance research methodologies.
Impact on businesses
- Business Growth: Powers business growth by unlocking new ideas and refining brand strategy.
- Informed Decision-Making: Provides data that helps brands define their position and improve customer-centricity.
Why it may fit your brief
Kadence excels at translating data into creative, actionable stories. It is a good fit for general marketing-led research rather than purely clinical or scientific data collection.
Yamada Research: best for multi-market healthcare fieldwork and respondent validation
Strongest fitBest for agencies or pharmaceutical firms needing a reliable fieldwork partner to manage complex, multi-market healthcare data collection.
Yamada Research provides specialized fieldwork and recruitment services in Thailand, focusing on the quality and reliability of data collection. The firm is structured to support global research agencies and healthcare organizations by managing complex, multi-market programs with a centralized quality control structure.
Their healthcare practice is particularly notable for its focus on verifying clinical profiles to make sure that respondents are not just claiming a role, but are actively engaged in the clinical work relevant to the study. The company is ISO certified, reflecting its disciplined approach to data security and project operations.
Scorecard: 72.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | yamadaresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | yamadaresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | yamadaresearch.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | yamadaresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | yamadaresearch.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | yamadaresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | yamadaresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | yamadaresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 72.5 |
Core services
- Healthcare Recruitment: Recruits verified physicians, specialists, nurses, and patients using strict clinical screening.
- Fieldwork Management: Manages both online and offline fieldwork, protecting consistent quality across multiple markets.
- Quality Control and Validation: Applies manual and logic-based checks to validate every respondent before delivery.
- Multi-Market Coordination: Centralizes quota tracking and reporting for single- and multi-country research programs.
Strengths
- Strict Validation Standards: Applies screening and response checks adapted to the sensitivity and complexity of healthcare studies.
- Certified Operations: ISO 27001 and ISO 9001 certified, protecting rigorous data security and quality management.
- Thailand-Led Global Coordination: Uses a centralized accountability structure for predictable delivery across multiple geographies.
Innovation and technology
- Layered Quality Controls: Applies consistent screening and manual validation across every market to protect data integrity.
- Centralized Quota Tracking: Provides real-time visibility and consolidated reporting for complex multi-market studies.
Impact on businesses
- Reliable Insights: Delivers high-quality data that allows clients to make decisions with confidence.
- Operational Predictability: Keeps multi-market projects on track from feasibility through to final data delivery.
Why it may fit your brief
Yamada Research excels at the operational side of fieldwork and respondent verification. It is ideal for clients who already have a research strategy and need high-quality, reliable execution in Thailand.
InVeritas Research: best for difficult-to-reach healthcare professional recruitment
Strongest fitIdeal for projects requiring the recruitment of very niche medical specialists or high-level business decision-makers.
InVeritas Research operates as a fieldwork-focused agency in Thailand with a strong emphasis on medical and B2B markets. The firm is known for its capability to recruit challenging profiles, including specialist physicians and high-net-worth individuals.
The agency provides both quantitative and qualitative services, including CATI, CAPI, and focus groups. They emphasize a dedicated project management approach, where every project is overseen by a director to protect consistent communication and quality control.
Scorecard: 70.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 70.5 |
Core services
- HCP Recruitment: Specializes in recruiting difficult-to-reach specialists such as transplant surgeons and pediatric oncologists.
- Quantitative Fieldwork: Executes large-scale data collection via CATI, CAPI, and face-to-face interviews.
- Qualitative Services: Supports focus groups, dyads, and IDIs with professional respondents.
- Consulting and Analytics: Provides analytical support to help clients make commercially sound decisions based on real-world data.
Strengths
- Niche Recruitment Capability: Proven track record in reaching specialists and hard-to-reach decision-makers.
- Quality Control SOPs: Follows strict quality control protocols with every deliverable checked by a dedicated team and project directors.
- Full-Service Execution: Combines expert recruitment with end-to-end project management and analytical support.
Innovation and technology
- Custom Research Approach: Tailors sampling plans and methodology based on the unique requirements of each project.
- Multi-Disciplinary Teams: Uses teams with specific expertise in both qualitative and quantitative methodologies.
Impact on businesses
- Competitive Edge: Provides real-world data that enables stakeholders to make bold decisions for brand leadership.
- Actionable Findings: Delivers insights that allow businesses to outperform in local target markets.
Why it may fit your brief
InVeritas is highly effective at recruitment, making it a great partner for studies involving small, specialized physician groups. It is less focused on large-scale consumer brand health tracking.
2insights: best for agile survey programming and AI-assisted data collection
Strongest fitSuitable for clients needing fast turnaround times and technology-integrated research for niche patient populations.
2insights provides research services in Thailand with a focus on integrating technology into the data collection process. The firm employs AI-driven tools, including chatbots and virtual moderators, to engage target audiences and accelerate project timelines.
Their healthcare practice covers a broad spectrum, from consumer healthcare products to rare disease research. They emphasize their ability to provide end-to-end service, taking projects from initial concept through to final reporting and implementation.
Scorecard: 66.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | 2insights.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 66.0 |
Core services
- Survey Programming: Uses diverse programming tools to create effective online surveys for rapid data collection.
- AI-Driven Data Collection: Uses chatbots and virtual moderators to automate respondent engagement.
- Rare Disease Research: Specializes in recruiting and studying low-incidence patient populations in healthcare.
- Analytical Reporting: Provides high-level analysis to help clients make informed strategic decisions.
Strengths
- Technology-Forward: Applies AI to analyze responses in real-time for a faster project turnaround.
- Global Reach: Maintains field-support and data collection teams worldwide to handle multi-market projects.
- Expertise in Rare Disease: Strong specialization in difficult-to-reach patient groups within the healthcare sector.
Innovation and technology
- Virtual Moderators: Uses digital tools to support qualitative discussions and engage respondents remotely.
- Predictive AI Analytics: Provides a predictive edge by processing and analyzing survey responses in real-time.
Impact on businesses
- Strategic Decision Support: Helps clients make informed decisions by providing deep, reliable analytical insights.
- Efficiency Gains: Automates data collection to solve complicated research needs with speed and effectiveness.
Why it may fit your brief
2insights is well-suited for agile research projects and rare disease recruitment. It may be less appropriate for brands needing long-term, traditional ethnography or deep, face-to-face consultative relationships.
Acorn Asia: best for problem-solving qualitative and brand health research
Strongest fitBest for consumer-focused brands seeking deep qualitative insights into brand perception and positioning.
Acorn Asia acts as a regional research provider in Thailand, positioning market research as a blend of science and art. The agency emphasizes the importance of understanding the consumer as a person to guide brand and product development.
Their approach is highly qualitative, focusing on deep dives into consumer needs and perceptions. They offer a range of specialized models for brand health tracking and market segmentation to help clients strengthen their brand architecture.
Scorecard: 65.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | acornasia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | acornasia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | acornasia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | acornasia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | acornasia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | acornasia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | acornasia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | acornasia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 65.0 |
Core services
- Brand Strategy Development: Crafts brand architectures and guidelines based on deep consumer understanding.
- Brand Health Monitoring: Tracks brand equity and communication effectiveness over time.
- Customer Experience Optimization: Improves user experiences through targeted market research and mystery shopping.
- Market Opportunity Analysis: Conducts segmentation and construction studies to identify new growth areas.
Strengths
- Consumer-Centric Lens: Focuses on the complex needs and desires of consumers to drive brand strength.
- Scientific Research Models: Uses established frameworks to analyze the market in creative and breakthrough ways.
- Deep Generalist Expertise: Provides a wide range of analytical tools suitable for various consumer-facing industries.
Innovation and technology
- Product Values Probes: Specialized research techniques to uncover the hidden drivers behind product acceptance.
- Internal Brand Alignment: Assists with internal activation to make sure brand messaging is consistent across the organization.
Impact on businesses
- Stronger Brands: Helps clients make decisions that never compromise the integrity of their product or brand.
- Actionable Insight: Communicates complex data in ways that drive immediate marketing action.
Why it may fit your brief
Acorn Asia provides a strong qualitative foundation for consumer-health brands. It may be less suitable for projects requiring large, verified clinical panels or specialized medical-device technical expertise.
How HCP and patient verification actually works in Thailand
Verify that your provider uses multi-step identity and license-based checks for healthcare professionals rather than relying on self-reported data.
Licence and Registration Validation
For healthcare professionals, the gold standard is verifying the respondent's national medical license or professional registration number. Ask the agency to provide their standard operating procedure for this verification. A reliable firm will perform these checks during the initial recruitment phase and periodically re-validate them. If an agency cannot provide evidence of how they confirm a physician's credentials, the risk of non-clinical respondents entering your sample increases, which can lead to skewed, unreliable data.
Multi-Factor Identity Fingerprinting
Beyond credentials, use technology-based verification like device fingerprinting and geo-location checks to make sure the respondent is who they claim to be. This prevents fraudulent actors from using VPNs to mask their location or setting up multiple accounts. Good providers use a combination of these digital tools alongside trap questions during the survey to catch participants who are not paying attention or are using automated scripts.
Patient Profile Authenticity
Validating patients is inherently harder than professionals, but it can be done through third-party health record verification or by requiring proof of diagnosis, such as anonymized medical records or prescription documentation. Ask for their specific process for verifying rare disease or chronic condition patients. Be wary of agencies that use open, non-proprietary panels, as these are significantly more susceptible to professional survey-takers who misrepresent their health status to qualify for incentives.
Adverse Event Protocol Integration
A important part of healthcare research verification is making sure the agency can handle adverse events correctly. Ask for their written protocol for reporting safety information to your pharmacovigilance team. The agency must be able to identify, log, and report these events according to the guidelines set by bodies like the BHBIA. If a firm does not have a formal, documented process for this, they pose a significant compliance risk to your pharmaceutical brand.
How to choose the right provider in Thailand
Select a partner based on their ability to match your specific study needs, whether that is high-volume quantitative data or deep-dive qualitative clinical research.
- Define Research Objectives Clearly: Start by deciding if you need broad market tracking or deep, niche-audience qualitative work. Agencies that are excellent at large-scale survey programming may struggle with the sensitive, in-depth interviews required for rare disease research.
- Assess Proprietary Panel Access: Ask if the agency owns their panels or if they are renting them from third-party networks. Proprietary panels are significantly more reliable because the agency controls the quality, profiling, and recruitment of the members.
- Demand Compliance Documentation: Request proof of certifications like ISO 20252 and ISO 27001. A partner in the pharmaceutical sector must demonstrate how they handle sensitive health data under local law and how they report adverse events.
- Evaluate Feasibility Honestly: Request a feasibility check for your target audience before committing to a project. A good partner will be transparent about the incidence rate of your required profile and suggest alternative methodologies if the initial plan is too ambitious.
- Review Data Quality Controls: Ask for the specific steps taken to clean data, such as trap questions and identity verification. You want to see a proactive approach to removing fraudulent completes before they reach your final dataset.
Questions to ask before you commission
- What specific steps do you take to verify the clinical credentials of physicians in Thailand?
- Can you describe your adverse event reporting protocol in detail?
- What is the source of your healthcare professional and patient panels?
- How do you handle low-incidence recruitment in the Thai market?
- What specific data cleaning and fraud detection tools do you use for online surveys?
- Can you provide a redacted example of how you report feasibility and incidence for a project?
Common pitfalls to avoid
- Over-relying on Generalist Panels: Using general-population consumer panels for pharmaceutical research often results in low-quality data from non-verified individuals, which can severely compromise your clinical findings.
- Ignoring Adverse Event Reporting: Failing to establish a clear adverse event reporting process before fieldwork begins can result in major regulatory and compliance failures for your pharmaceutical brand.
- Assuming One-Size-Fits-All Recruitment: Expecting the same recruitment speed for a common condition patient as for a rare-disease specialist is a common error that leads to delayed projects and frustrated stakeholders.
- Neglecting Local Data Privacy: Treating patient data without strict adherence to Thailand's data protection laws can lead to severe legal consequences and damage your organization's reputation.
What a feasibility check should include
A comprehensive feasibility check must account for the actual availability of your specific medical audience, the required screening criteria, and the project timeline.
Audience Incidence Rates
The check should confirm the true incidence rate of your target population, as overly optimistic estimates often lead to significant recruitment delays in the Thai healthcare market.
Screening Complexity
A proper check evaluates how many screening criteria are needed; the more criteria, the harder the recruitment, and a good agency will warn you if your requirements are too restrictive.
Geographic and Access Constraints
It must verify if your audience is restricted to specific hospital types or regions in Thailand, as some specialists are only reachable through specific medical channels.
Timeline Realism
Finally, the check should provide a realistic fieldwork duration based on historical recruitment data for that specific audience, making sure your brand manager is not working toward an impossible deadline.
Conclusion
Choosing the right partner from the list of pharmaceutical research companies in Thailand requires balancing clinical accuracy with commercial speed. For large-scale predictive modeling and commercial data analysis, IQVIA remains the standard. If your brand needs deep consumer-health tracking or media effectiveness studies, Kantar and Ipsos offer the necessary scale and analytical breadth.
However, for studies where respondent quality, clinical verification, and regulatory compliance are the top priority, such as physician-led research or patient journey mapping, Global Vox Populi provides the most specialized, high-compliance infrastructure. Use the scorecard provided to weigh these providers against your specific project requirements, protecting you prioritize verified clinical panels over generalist networks to protect the integrity of your strategic decisions.
Planning research in Thailand? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
How do I find a reliable pharmaceutical market research agency in Thailand?
Look for agencies that maintain proprietary healthcare panels rather than those using rented, multi-market sample networks. Verify their experience in the medical sector by asking for their adverse event reporting protocols and their process for verifying physician or patient credentials. Reliable partners will be transparent about their feasibility and will provide documented evidence of their compliance with ISO and data protection standards.
What are the top healthcare market research firms in Bangkok?
Several firms provide healthcare research in Bangkok, each with different strengths. IQVIA is the primary choice for large-scale data and clinical analytics. Global Vox Populi is a leading specialist for verified HCP and patient research. Kantar and Ipsos are effective for brand health and consumer-health tracking, while firms like Yamada Research and InVeritas specialize in the operational aspects of fieldwork and specialist recruitment.
Does IQVIA provide market research services in Thailand?
Yes, IQVIA provides a comprehensive suite of commercial and clinical research services in Thailand. They are well-known for their expertise in prescription data analytics, physician panels, and real-world evidence generation. Their services are designed for life sciences organizations looking for large-scale data to inform commercial strategy and clinical trial optimization.
How is the pharmaceutical market in Thailand researched?
Research in Thailand typically involves a mix of quantitative and qualitative methods. This includes large-scale surveys of physicians and pharmacists to track prescribing habits and market shares, as well as qualitative deep dives like focus groups and in-depth interviews with patients to map their treatment journeys. Increasingly, predictive analytics and real-world evidence are used to supplement traditional primary research data.
Are there specialized healthcare fieldwork agencies in Thailand?
Yes, there are agencies that specialize in the operational fieldwork required for healthcare research. For example, Yamada Research and InVeritas Research are dedicated to managing the complex recruitment and data collection processes for medical and pharmaceutical clients. These firms are particularly useful for brands that already have a research strategy and need a reliable partner to protect high-quality fieldwork execution.
What is the difference between a CRO and a pharmaceutical market research agency?
A Clinical Research Organization (CRO) is primarily focused on the clinical development process, such as managing clinical trials for drug approval. A pharmaceutical market research agency focuses on commercial and strategic insights, such as understanding market access, brand positioning, and the needs of prescribers and patients. While some firms offer both, they are fundamentally different in their objectives, regulatory requirements, and the nature of the data they handle.
How do I choose a market research partner for the Thai healthcare sector?
Choosing a partner should start with a clear definition of your project's objectives. If you need highly specialized, clinical research, prioritize agencies with proprietary, verified panels like Global Vox Populi. If you need large-scale commercial data, consider IQVIA. Always verify their compliance certifications and their ability to handle adverse event reporting, as these are non-negotiable for pharmaceutical brands in Thailand.
What are the main challenges when conducting pharma research in Thailand?
The primary challenges include accessing niche medical specialists, protecting the data quality of online healthcare panels, and working through complex regulatory requirements regarding patient data. There is also the significant risk of fraudulent survey responses, which requires agencies to use advanced digital fingerprinting and manual validation to make sure the insights you receive are from real, qualified professionals.